Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Other Current Assets

Current assets not reported separately, such as prepaid expenses.

No reported Other Current Assets figures are available to summarize.

Other Current Assets history

Currency unavailable · from the balance sheet

No Other Current Assets data reported for this period type.

Other Current Assets vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Other Current Assets for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SYRESpyre Therapeutics, Inc.Sep 2026$27.82M USD+51.2%+51.0%2.5%
ALMSAlumis Inc. Common StockJun 2026$7.93M USD-66.1%+233.6%1.4%
ANABAnaptysBio, Inc.Mar 2026$3.91M USD-26.2%+1.6%1.2%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€3.43M EUR——2.1%
PTGXProtagonist Therapeutics, Inc.Jun 2026$3.37M USD——0.4%
IMUXImmunic, Inc.Mar 2026$1.06M USD-54.7%-30.6%0.6%
ORKAOruka Therapeutics, Inc.Sep 2026$0 USD-100.0%+199.3%0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD-100.0%+59.8%0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-60.4%+55.4%0.9%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.